The Effects of 6-Month DPP-4 inhibitor Treatment in Diabetic Patients during Oral Glucocorticoids Administration

The Effects of 6-Month DPP-4 inhibitor Treatment in Diabetic Patients during Oral Glucocorticoids Administration - The Effects of 6-Month DPP-4 inhibitor Treatment in Diabetic Patients during Oral Glucocorticoids Administration

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000014508

Enrollment

Registered

2014-07-08

Start date

2014-04-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diabetic patients who had taken sitagliptin and oral corticosteroids for 6 months or longer

Exclusion criteria

Exclusion criteria: Type 1 diabetes

Design outcomes

Primary

Measure	Time frame
Body weight, HbA1c (NGSP)	—

Countries

Japan

Contacts

Public ContactHisayuki Katsuyama

National Center for Global Health and Medicine, Kohnodai Hospital Department of Internal Medicine

katsuyama-hs@umin.ac.jp+81-47-372-3501

Outcome results